Tralokinumab
Product Specifications
CAS Number
1044515-88-9
Target
Interleukin, Cadherin, Caspase, Apoptosis, IL Receptor
Related Pathways
Cytoskeletal Signaling, Apoptosis, Immunology/Inflammation, Proteases/Proteasome
Purity
1
Bioactivity
Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumab's potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog